IMRT (Intensity-Modulated Radiation Therapy)

RADIATION2 trials

Sponsors

University of Michigan Rogel Cancer Center, Memorial Sloan Kettering Cancer Center

Conditions

Head and Neck Squamous Cell CancerSquamous Cell Carcinoma of the Head and Neck

Phase 1

Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)

CompletedNCT02282371

Memorial Sloan Kettering Cancer CenterHead and Neck Squamous Cell Cancer

Start: 2014-10-30End: 2021-10-22Target: 16Updated: 2021-10-26

Phase 2

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

CompletedNCT02031250

University of Michigan Rogel Cancer CenterSquamous Cell Carcinoma of the Head and Neck

Start: 2014-02-01End: 2023-02-22Updated: 2026-03-02

Related Papers

Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology2017-05-203 citations